Axial spondyloarthritis Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: 1. Adults aged 18 years old and over 2. A confirmed diagnosis of axSpA 3. Registered with participating rheumatology centres 4. Access to a computer or tablet device to allow for receipt of the e-mail and e-WASTEd completion Health professionals: Experience of using the BSR ePROM portal with their patients
Exclusion criteria
Exclusion criteria: 1. Ability to understand written English to a readability level of 11-13 years 2. Patients with significant co-morbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue and energy measured using the WASTEd 18-item questionniare at baseline, 2-week and 3-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures are assessed at baseline, 2-week and 3-month follow-up: 1. Health-related quality of life measured using the EQ-5D five questionnaire descriptive system and the EQ visual analogue scale (EQ VAS) 2. Self-reported fatigue and its impact upon daily activities and function measured using the Functional Assessment of Chronic Illness Therapy – Fatigue Scale (FACIT-Fatigue) 5-point Likert-type scale comprising 13 items 3. Anxiety and depression symptoms measured using the Hospital Anxiety and Depression Score (HADS) 4-point Likert-type scale comprising 14 items 4. Pain measured using a single measure of pain severity using an 11-point numerical rating scale 5. Four domains of physical function, disease activity, emotional well-being and social participation measured using the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) 5-point Likert-type scale comprising 20 items 6. Functional and disease activity indices measured using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) comprising a 0 - 10 scale measuring discomfort, pain, and fatigue (0 being no problem and 10 being the worst problem) in response to six questions 7. Functional anatomical limitations due to the course of this inflammatory disease and the patient’s ability to cope with everyday life measured using the Bath Ankylosing Spondylitis Functional Index (BASFI) comprising 10 VAS questions | — |
Countries
England, Scotland, United Kingdom, Wales